Evaluation of XYA02 in Patients With Advanced Solid Tumors

Clinical trial NCT07670312 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07670312
Sponsor: XYone Therapeutics, Inc
Status: NOT_YET_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

MUC1-expressing Advanced, Relapsed and/or Refractory Solid Tumors Non-Small Cell Lung Cancer Ovarian Cancer GEJ Adenocarcinoma Colorectal Cancer Pancreatic Adenocarcinoma

Start date: 2026-07-15
Primary completion: 2029-07-15
Enrollment: 190

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.